William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
-
Agenus to Participate in Webcast Hosted by William Blair to Discuss AGEN1181 Clinical Data from SITC 2021 Meeting
-
Agenus to Participate in Webcast Hosted by William Blair to Discuss AGEN1181 Clinical Data from SITC 2021 Meeting
-
Agenus to Participate in Resistance-Focused Oncology Panel at the William Blair Biotech Focus Conference 2021
-
Agenus to Participate in Resistance-Focused Oncology Panel at the William Blair Biotech Focus Conference 2021
-
New Clinical Responses for AGEN1181 Presented at AACR
-
New Clinical Responses for AGEN1181 Presented at AACR
-
Agenus to Participate in Webcast Hosted by William Blair on AGEN1181 and Balstilimab AACR Presentations
-
Agenus to Participate in Webcast Hosted by William Blair on AGEN1181 and Balstilimab AACR Presentations
-
Agenus and Dr. Steven O’Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data
-
Agenus and Dr. Steven O’Day to Participate in Webcast Hosted by William Blair on AGEN1181 and SITC Data
-
Agenus to Participate in Webcast Hosted by William Blair on ESMO2020 Results and Novel Pipeline
-
Agenus to Participate in Webcast Hosted by William Blair on ESMO2020 Results and Novel Pipeline
-
Agenus to Present on Targeting Myeloid Cells in Tumor Microenvironment at the William Blair Biotech Focus 2020 Conference
-
Agenus to Present at Healthcare Investor Conferences In April
-
Agenus to Participate at Two Upcoming Immuno-Oncology Conferences
-
Agenus to Participate at Three Upcoming Oncology Conferences
-
Agenus Announces Closing of Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares of Common Stock
-
UPDATE: Agenus (AGEN) Prices 11M Common Offering at $6.30/Share
-
Agenus Announces Pricing of Its Public Offering of Common Stock
-
Agenus (AGEN) Announces Common Stock Offering
-
Agenus Announces Proposed Public Offering of Common Stock
-
Agenus Inc. (AGEN) Commences Offering
-
Morning Movers 01/06: (BDSI) (SABA) (XIDE) (AGEN) Higher; (DRRX) (RFMD) (IART) (PSMT) (SNTA) Lower
-
William Blair Starts Agenus Inc. (AGEN) at Outperform

